Back
MetLife Vs. Bright Minds Biosciences Industry Stock Comparison
Buy
58
MET
MetLife
Last Price:
$83.08
Seasonality Move:
1.16%
Sell
34
DRUG
Bright Minds Biosciences
Last Price:
$37.75
Seasonality Move:
-43.47%
Sell
34
Bright Minds Biosciences (DRUG)
is a Sell
Is Bright Minds Biosciences a Buy, Sell or Hold?
-
The current Bright Minds Biosciences [DRUG] share price is $37.51. The Score for DRUG is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
DRUG is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DRUG Stock Price Chart
What is Bright Minds Biosciences's stock price today?
-
The Bright Minds Biosciences share price today is $37.51The current trend is moderately bearish and DRUG is experiencing selling pressure, which indicates risk of future bearish movement.
MET Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.48 | Sell |
Relative Strength Index (14 RSI): | 42.27 | Sell |
Chaikin Money Flow: | 3963467 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (83.05 - 86.53) | Sell |
Bollinger Bands (100): | (81.12 - 85.68) | Sell |
DRUG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.65 | Buy |
Relative Strength Index (14 RSI): | 46.64 | Sell |
Chaikin Money Flow: | -71076 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.16 - 42.24) | Buy |
Bollinger Bands (100): | (19.38 - 49.24) | Buy |
MET Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 82.88 | Sell |
20-day SMA: | 84.82 | Sell |
50-day SMA: | 83.49 | Sell |
200-day SMA: | 78.12 | Buy |
8-day EMA: | 82.97 | Sell |
20-day EMA: | 83.81 | Sell |
50-day EMA: | 83.67 | Sell |
200-day EMA: | 78.93 | Buy |
DRUG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 43.36 | Sell |
20-day SMA: | 37.5 | Buy |
50-day SMA: | 38.2 | Sell |
200-day SMA: | 17.71 | Buy |
8-day EMA: | 41.53 | Sell |
20-day EMA: | 39.63 | Sell |
50-day EMA: | 37.64 | Sell |
200-day EMA: | 23.31 | Buy |
MetLife Earnings Growth & MET Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.08 per share, an increase this year of $1.33 per share, and an increase next year of $1.08 per share.
Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.10 per share, a decrease this year of $1.07 per share, and a decrease next year of $1.22 per share.
MetLife Technical Analysis
Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Bright Minds Biosciences Technical Analysis
Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |